4//SEC Filing
Schaeffer Orlov S Nicole 4
Accession 0001401017-25-000010
CIK 0001104506other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:23 PM ET
Size
14.4 KB
Accession
0001401017-25-000010
Insider Transaction Report
Form 4
INSMED IncINSM
Schaeffer Orlov S Nicole
Chief People Strategy Officer
Transactions
- Sale
Common Stock
2025-09-12$144.60/sh−32,091$4,640,359→ 80,890 total - Exercise/Conversion
Stock Option (right to buy)
2025-09-12−56,520→ 0 totalExercise: $23.75Exp: 2030-01-03→ Common Stock (56,520 underlying) - Exercise/Conversion
Common Stock
2025-09-12$23.75/sh+56,520$1,342,350→ 112,981 total - Sale
Common Stock
2025-09-12$145.67/sh−30,967$4,510,963→ 49,923 total - Sale
Common Stock
2025-09-12$147.46/sh−6,158$908,059→ 36,461 total - Sale
Common Stock
2025-09-12$146.57/sh−7,304$1,070,547→ 42,619 total
Footnotes (6)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]This is the weighted average sales price representing 32,091 shares sold at prices ranging from $144.06 to $145.05 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F3]This is the weighted average sales price representing 30,967 shares sold at prices ranging from $145.06 to $146.02 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F4]This is the weighted average sales price representing 7,304 shares sold at prices ranging from $146.08 to $147.06 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F5]This is the weighted average sales price representing 6,158 shares sold at prices ranging from $147.12 to $148.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F6]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Documents
Issuer
INSMED Inc
CIK 0001104506
Entity typeother
Related Parties
1- filerCIK 0001401017
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:23 PM ET
- Size
- 14.4 KB